Tina Regan, 68, has been touched by cancer personally and has seen the devastating impact it has had on her immediate family. That is why she has pledged to leave a gift in her Will to fund our vital ...

We are very grateful that so many of you recognise the cutting-edge research carried out at The Institute of Cancer Research.

Scientists have developed a tool which helps them better understand cancer’s survival tactics and could eventually lead to new treatments for dozens of cancer types. Some cancers are caused by ...

Rider McDowell’s son Errol was diagnosed with medulloblastoma, a fast-growing malignant brain tumour, when he was 12. Despite six years of intensive treatment, Errol passed away in 2018. Before he ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

The Breast Cancer Now Toby Robins Research Centre at the ICR receives funding from the charity Breast Cancer Now, and was opened in 1999 by Breast Cancer Now's Patron, HRH The Prince of Wales. The ...

Scientists at The Institute of Cancer Research, London, are partnering with Revolver Therapeutics to accelerate the development of pioneering drugs for treating incurable childhood brain tumours.

Researchers have uncovered several biological signs that may determine how metastatic castration-resistant prostate cancer (mCRPC) responds to a new treatment combination. The scientists made these ...